Perspectives and Attitudes on the Use of Adjuvant Chemotherapy and Hormonal Therapy in Older and/or Frail Women: A Survey of Oncologists and Geriatricians
N/A
N/A
Both
Breast Cancer
Trial Information
Perspectives and Attitudes on the Use of Adjuvant Chemotherapy and Hormonal Therapy in Older and/or Frail Women: A Survey of Oncologists and Geriatricians
OBJECTIVES:
- Evaluate the attitudes and perspectives of 150 oncologists and 150 geriatricians or
primary care providers regarding the adjuvant treatment of older women with breast
cancer of varying ages, health, and functional status.
- Determine whether homogeneity exists in treatment recommendations.
- Determine the relative impact of chronological age, baseline health, and functional
status on treatment recommendations.
OUTLINE: Participants complete a 25-minute online survey regarding their treatment
recommendations for older women with breast cancer of varying ages, health, and functional
status.
PROJECTED ACCRUAL: A total of 300 participants will be accrued for this study.
Inclusion Criteria
DISEASE CHARACTERISTICS:
- Participants must meet 1 of the following criteria:
- Oncologist:
- Must have been in practice ≥ 2 years
- Must have ≥ 25 postmenopausal breast cancer patients on adjuvant hormonal
therapy
- Cannot work for an advertising agency, market research company,
manufacturer or distributor of pharmaceutical products, a pharmacy, drug
store, or the FDA
- Geriatrician:
- Must have been in practice ≥ 2 years
- Must be a general practitioner, family practitioner, internal medicine
specialist, or geriatrician and received a certificate of added
qualification in geriatric medicine and/or treating at least 5
postmenopausal patients who have a history of breast cancer or are
currently undergoing treatment for breast cancer
- Cannot work for an advertising agency, market research company,
manufacturer or distributor of pharmaceutical products, a pharmacy, drug
store, or the FDA
PATIENT CHARACTERISTICS:
- Not specified
PRIOR CONCURRENT THERAPY:
- Not specified
Type of Study:
Interventional
Study Design:
Primary Purpose: Health Services Research
Outcome Measure:
Attitudes and perspectives of health professionals
Safety Issue:
No
Principal Investigator
Arti Hurria, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Beckman Research Institute
Authority:
United States: Federal Government
Study ID:
CDR0000540280
NCT ID:
NCT00478283
Start Date:
December 2006
Completion Date:
October 2007
Related Keywords:
- Breast Cancer
- breast cancer
- Breast Neoplasms
Name | Location |
|---|
